1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 Rajagopal, P. Klevit, R.E. Shi, L. Baker, D. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H10 N3 O2 1 156.162 y HISTIDINE L-peptide linking C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C5 H11 N O2 S 149.211 y METHIONINE L-peptide linking C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking US Elife 2050-084X 4 10.7554/eLife.07304 25962097 A conserved histidine modulates HSPB5 structure to trigger chaperone activity in response to stress-related acidosis. 2015 UK J.Mol.Biol. JMOBAK 0070 0022-2836 385 1481 1497 10.1016/j.jmb.2008.10.097 19041879 alphaB-crystallin: a hybrid solid-state/solution-state NMR investigation reveals structural aspects of the heterogeneous oligomer. 2009 US Nat.Struct.Mol.Biol. 1545-9993 17 1037 1042 10.1038/nsmb.1891 20802487 Solid-state NMR and SAXS studies provide a structural basis for the activation of alphaB-crystallin oligomers. 2010 US Proc.Natl.Acad.Sci.USA PNASA6 0040 0027-8424 108 6409 6414 10.1073/pnas.1014656108 21464278 N-terminal domain of alphaB-crystallin provides a conformational switch for multimerization and structural heterogeneity. 2011 10.2210/pdb2n0k/pdb pdb_00002n0k 10200.497 Alpha-crystallin B chain unp residues 64-152 N146D 2 man polymer Alpha(B)-crystallin, Heat shock protein beta-5, HspB5, Renal carcinoma antigen NY-REN-27, Rosenthal fiber component no no GLSEMRLEKDRFSVNLDVKHFSPEELKVKVLGDVIEVHGKHEERQDEHGFISREFHRKYRIPADVDPLTITSSLSSDGVL TVDGPRKQV GLSEMRLEKDRFSVNLDVKHFSPEELKVKVLGDVIEVHGKHEERQDEHGFISREFHRKYRIPADVDPLTITSSLSSDGVL TVDGPRKQV A,B polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n human sample CRYA2, CRYAB 9606 Homo sapiens 469008 Escherichia coli BL21 (DE3) pET24a database_2 pdbx_database_status pdbx_nmr_software pdbx_nmr_spectrometer struct_ref_seq_dif struct_sheet repository Initial release Database references Database references Data collection Database references Derived calculations Other 1 0 2015-06-03 1 1 2015-07-22 1 2 2017-02-15 1 3 2023-06-14 _database_2.pdbx_DOI _database_2.pdbx_database_accession _pdbx_database_status.status_code_nmr_data _pdbx_nmr_software.name _pdbx_nmr_spectrometer.model _struct_ref_seq_dif.details _struct_sheet.number_strands NMR distance, dihedral, and residual dipolar coupling constraints. BMRB Y RCSB 2015-03-09 REL REL REL REL 838 310 188 85 255 72 72 Solution structure was determined with NOEs and RDCs. structures with the lowest energy 100 9 2D 1H-15N HSQC 2D 1H-15N HSQC 2D 1H-15N HSQC 3D 1H-15N NOESY 2D 1H-13C HSQC aliphatic 2D 1H-13C HSQC aromatic 3D HNCACB 3D HBHA(CO)NH 3D HNCO 3D HNCA 3D HN(CO)CA 3D HN(COCA)CB 3D HCCH-TOCSY 3D H(CCO)NH 3D C(CO)NH 0.2-1.0 mM [U-100% 13C; U-100% 15N] 50 mM 100 mM .1 mM 1 mM 0.2-1.0 mM [U-100% 13C; U-100% 15N; U-80% 2H] 50 mM 100 mM .1 mM 1 mM 0.2-1.0 mM [U-100% 13C; U-100% 15N; U-80% 2H] 50 mM 100 mM .1 mM 1 mM 14 mg/mL 1.0 mM [U-100% 13C; U-100% 15N] 50 mM 100 mM .1 mM 1 mM 1.0 mM [U-100% 13C; U-100% 15N; 50% 2H] 50 mM 100 mM .1 mM 1 mM 100 7.5 ambient 295 K 100 6.5 ambient 295 K simulated annealing 1 closest to the average 0.6 mM [U-100% 13C; U-100% 15N] HSPB5-ACD, 50 mM sodium phosphate, 100 mM sodium chloride, .1 mM EDTA, 1 mM PMSF, 90% H2O/10% D2O 90% H2O/10% D2O 0.6 mM [U-100% 13C; U-100% 15N; U-80% 2H] HSPB5-ACD, 50 mM sodium phosphate, 100 mM sodium chloride, .1 mM EDTA, 1 mM PMSF, 90% H2O/10% D2O 90% H2O/10% D2O 0.6 mM [U-100% 13C; U-100% 15N; U-80% 2H] HSPB5-ACD, 50 mM sodium phosphate, 100 mM sodium chloride, .1 mM EDTA, 1 mM PMSF, 14 mg/mL Pf1 phage, 90% H2O/10% D2O 90% H2O/10% D2O 1.0 mM [U-100% 13C; U-100% 15N] HSPB5-ACD, 50 mM sodium phosphate, 100 mM sodium chloride, .1 mM EDTA, 1 mM PMSF, 100% D2O 100% D2O 1.0 mM [U-100% 13C; U-100% 15N; 50% 2H] HSPB5-ACD, 50 mM sodium phosphate, 100 mM sodium chloride, .1 mM EDTA, 1 mM PMSF, 90% H2O/10% D2O 90% H2O/10% D2O Delaglio, Grzesiek, Vuister, Zhu, Pfeifer and Bax data analysis NMRPipe Delaglio, Grzesiek, Vuister, Zhu, Pfeifer and Bax processing NMRPipe Delaglio, Grzesiek, Vuister, Zhu, Pfeifer and Bax peak picking NMRPipe Johnson, One Moon Scientific data analysis NMRView Johnson, One Moon Scientific chemical shift assignment NMRView Johnson, One Moon Scientific peak picking NMRView Zimmerman, Moseley, Kulikowski and Montelione chemical shift assignment AutoAssign Zimmerman, Moseley, Kulikowski and Montelione peak picking AutoAssign Shen, Vernon, Baker and Bax structure solution CS-ROSETTA Shen, Vernon, Baker and Bax chemical shift assignment CS-ROSETTA Shen, Vernon, Baker and Bax peak picking CS-ROSETTA (RosettaOligomer)-Sgourakis, Lange, DiMaio, Andre, Fitzkee, Rossi, Montelione, Bax, Baker structure solution RosettaOligomer (RosettaOligomer)-Sgourakis, Lange, DiMaio, Andre, Fitzkee, Rossi, Montelione, Bax, Baker chemical shift assignment RosettaOligomer (RosettaOligomer)-Sgourakis, Lange, DiMaio, Andre, Fitzkee, Rossi, Montelione, Bax, Baker peak picking RosettaOligomer Cornilescu, Delaglio and Bax refinement TALOS Cornilescu, Delaglio and Bax chemical shift assignment TALOS Cornilescu, Delaglio and Bax peak picking TALOS (GUARDD)-Kleckner, Foster data analysis GUARDD (GUARDD)-Kleckner, Foster chemical shift assignment GUARDD (GUARDD)-Kleckner, Foster peak picking GUARDD refinement RosettaOligomer 800 Bruker AVANCE Bruker Avance 600 Bruker AVANCE Bruker Avance 500 Bruker AVANCE Bruker Avance 900 Bruker AVANCE Bruker Avance GLY 64 n 1 GLY 64 A LEU 65 n 2 LEU 65 A SER 66 n 3 SER 66 A GLU 67 n 4 GLU 67 A MET 68 n 5 MET 68 A ARG 69 n 6 ARG 69 A LEU 70 n 7 LEU 70 A GLU 71 n 8 GLU 71 A LYS 72 n 9 LYS 72 A ASP 73 n 10 ASP 73 A ARG 74 n 11 ARG 74 A PHE 75 n 12 PHE 75 A SER 76 n 13 SER 76 A VAL 77 n 14 VAL 77 A ASN 78 n 15 ASN 78 A LEU 79 n 16 LEU 79 A ASP 80 n 17 ASP 80 A VAL 81 n 18 VAL 81 A LYS 82 n 19 LYS 82 A HIS 83 n 20 HIS 83 A PHE 84 n 21 PHE 84 A SER 85 n 22 SER 85 A PRO 86 n 23 PRO 86 A GLU 87 n 24 GLU 87 A GLU 88 n 25 GLU 88 A LEU 89 n 26 LEU 89 A LYS 90 n 27 LYS 90 A VAL 91 n 28 VAL 91 A LYS 92 n 29 LYS 92 A VAL 93 n 30 VAL 93 A LEU 94 n 31 LEU 94 A GLY 95 n 32 GLY 95 A ASP 96 n 33 ASP 96 A VAL 97 n 34 VAL 97 A ILE 98 n 35 ILE 98 A GLU 99 n 36 GLU 99 A VAL 100 n 37 VAL 100 A HIS 101 n 38 HIS 101 A GLY 102 n 39 GLY 102 A LYS 103 n 40 LYS 103 A HIS 104 n 41 HIS 104 A GLU 105 n 42 GLU 105 A GLU 106 n 43 GLU 106 A ARG 107 n 44 ARG 107 A GLN 108 n 45 GLN 108 A ASP 109 n 46 ASP 109 A GLU 110 n 47 GLU 110 A HIS 111 n 48 HIS 111 A GLY 112 n 49 GLY 112 A PHE 113 n 50 PHE 113 A ILE 114 n 51 ILE 114 A SER 115 n 52 SER 115 A ARG 116 n 53 ARG 116 A GLU 117 n 54 GLU 117 A PHE 118 n 55 PHE 118 A HIS 119 n 56 HIS 119 A ARG 120 n 57 ARG 120 A LYS 121 n 58 LYS 121 A TYR 122 n 59 TYR 122 A ARG 123 n 60 ARG 123 A ILE 124 n 61 ILE 124 A PRO 125 n 62 PRO 125 A ALA 126 n 63 ALA 126 A ASP 127 n 64 ASP 127 A VAL 128 n 65 VAL 128 A ASP 129 n 66 ASP 129 A PRO 130 n 67 PRO 130 A LEU 131 n 68 LEU 131 A THR 132 n 69 THR 132 A ILE 133 n 70 ILE 133 A THR 134 n 71 THR 134 A SER 135 n 72 SER 135 A SER 136 n 73 SER 136 A LEU 137 n 74 LEU 137 A SER 138 n 75 SER 138 A SER 139 n 76 SER 139 A ASP 140 n 77 ASP 140 A GLY 141 n 78 GLY 141 A VAL 142 n 79 VAL 142 A LEU 143 n 80 LEU 143 A THR 144 n 81 THR 144 A VAL 145 n 82 VAL 145 A ASP 146 n 83 ASP 146 A GLY 147 n 84 GLY 147 A PRO 148 n 85 PRO 148 A ARG 149 n 86 ARG 149 A LYS 150 n 87 LYS 150 A GLN 151 n 88 GLN 151 A VAL 152 n 89 VAL 152 A GLY 64 n 1 GLY 64 B LEU 65 n 2 LEU 65 B SER 66 n 3 SER 66 B GLU 67 n 4 GLU 67 B MET 68 n 5 MET 68 B ARG 69 n 6 ARG 69 B LEU 70 n 7 LEU 70 B GLU 71 n 8 GLU 71 B LYS 72 n 9 LYS 72 B ASP 73 n 10 ASP 73 B ARG 74 n 11 ARG 74 B PHE 75 n 12 PHE 75 B SER 76 n 13 SER 76 B VAL 77 n 14 VAL 77 B ASN 78 n 15 ASN 78 B LEU 79 n 16 LEU 79 B ASP 80 n 17 ASP 80 B VAL 81 n 18 VAL 81 B LYS 82 n 19 LYS 82 B HIS 83 n 20 HIS 83 B PHE 84 n 21 PHE 84 B SER 85 n 22 SER 85 B PRO 86 n 23 PRO 86 B GLU 87 n 24 GLU 87 B GLU 88 n 25 GLU 88 B LEU 89 n 26 LEU 89 B LYS 90 n 27 LYS 90 B VAL 91 n 28 VAL 91 B LYS 92 n 29 LYS 92 B VAL 93 n 30 VAL 93 B LEU 94 n 31 LEU 94 B GLY 95 n 32 GLY 95 B ASP 96 n 33 ASP 96 B VAL 97 n 34 VAL 97 B ILE 98 n 35 ILE 98 B GLU 99 n 36 GLU 99 B VAL 100 n 37 VAL 100 B HIS 101 n 38 HIS 101 B GLY 102 n 39 GLY 102 B LYS 103 n 40 LYS 103 B HIS 104 n 41 HIS 104 B GLU 105 n 42 GLU 105 B GLU 106 n 43 GLU 106 B ARG 107 n 44 ARG 107 B GLN 108 n 45 GLN 108 B ASP 109 n 46 ASP 109 B GLU 110 n 47 GLU 110 B HIS 111 n 48 HIS 111 B GLY 112 n 49 GLY 112 B PHE 113 n 50 PHE 113 B ILE 114 n 51 ILE 114 B SER 115 n 52 SER 115 B ARG 116 n 53 ARG 116 B GLU 117 n 54 GLU 117 B PHE 118 n 55 PHE 118 B HIS 119 n 56 HIS 119 B ARG 120 n 57 ARG 120 B LYS 121 n 58 LYS 121 B TYR 122 n 59 TYR 122 B ARG 123 n 60 ARG 123 B ILE 124 n 61 ILE 124 B PRO 125 n 62 PRO 125 B ALA 126 n 63 ALA 126 B ASP 127 n 64 ASP 127 B VAL 128 n 65 VAL 128 B ASP 129 n 66 ASP 129 B PRO 130 n 67 PRO 130 B LEU 131 n 68 LEU 131 B THR 132 n 69 THR 132 B ILE 133 n 70 ILE 133 B THR 134 n 71 THR 134 B SER 135 n 72 SER 135 B SER 136 n 73 SER 136 B LEU 137 n 74 LEU 137 B SER 138 n 75 SER 138 B SER 139 n 76 SER 139 B ASP 140 n 77 ASP 140 B GLY 141 n 78 GLY 141 B VAL 142 n 79 VAL 142 B LEU 143 n 80 LEU 143 B THR 144 n 81 THR 144 B VAL 145 n 82 VAL 145 B ASP 146 n 83 ASP 146 B GLY 147 n 84 GLY 147 B PRO 148 n 85 PRO 148 B ARG 149 n 86 ARG 149 B LYS 150 n 87 LYS 150 B GLN 151 n 88 GLN 151 B VAL 152 n 89 VAL 152 B author_defined_assembly 2 dimeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 1 B B HD1 HH11 HIS ARG 104 107 1.21 1 A A HD1 HH11 HIS ARG 104 107 1.21 2 B B HD1 HH11 HIS ARG 104 107 1.25 2 A A HD1 HH11 HIS ARG 104 107 1.25 3 B B HG H SER ASP 138 140 1.32 3 A A HG H SER ASP 138 140 1.33 3 A A HD1 HE HIS ARG 104 116 1.34 3 B B HD1 HE HIS ARG 104 116 1.34 4 A A HG H SER ASP 138 140 1.33 5 A A HG H SER VAL 138 142 1.32 6 B B HG H SER VAL 138 142 1.35 9 A B H O LYS PHE 121 113 1.60 1 A SER 66 -141.58 27.22 1 A GLU 71 -68.99 -179.25 1 A LYS 72 -29.53 -59.97 1 A ASP 73 -146.45 46.41 1 A HIS 101 -60.78 75.66 1 A ASP 109 -154.61 -147.75 1 B SER 66 -141.61 27.25 1 B GLU 71 -69.06 -179.37 1 B LYS 72 -29.29 -60.02 1 B ASP 73 -146.53 46.49 1 B HIS 101 -60.67 75.53 1 B ASP 109 -154.50 -147.61 2 A MET 68 -37.57 119.52 2 A LYS 72 -13.40 -70.44 2 A ASP 73 -143.05 44.42 2 A ARG 74 -170.82 135.76 2 A HIS 83 72.21 34.26 2 A LEU 94 -105.94 68.64 2 A LYS 103 -170.58 120.18 2 A ASP 109 -133.81 -157.87 2 A SER 136 -171.67 146.95 2 B MET 68 -37.57 119.48 2 B LYS 72 -13.60 -70.43 2 B ASP 73 -142.83 44.40 2 B ARG 74 -170.88 135.59 2 B HIS 83 72.25 34.24 2 B LEU 94 -105.97 68.63 2 B LYS 103 -170.53 120.19 2 B ASP 109 -133.85 -157.89 2 B SER 136 -171.65 146.98 3 A GLU 71 -114.56 -149.85 3 A ASP 73 -151.89 33.79 3 A PHE 75 -163.88 119.69 3 A VAL 81 -147.55 34.30 3 A HIS 101 -102.83 64.58 3 A ASP 109 -116.54 -147.73 3 A ARG 116 -108.72 75.77 3 A LYS 121 -67.12 76.87 3 A ARG 149 -59.40 171.64 3 B GLU 71 -114.70 -149.79 3 B ASP 73 -151.89 33.76 3 B PHE 75 -163.79 119.82 3 B VAL 81 -147.55 34.17 3 B HIS 101 -102.86 64.60 3 B ASP 109 -116.51 -147.77 3 B ARG 116 -108.64 75.72 3 B LYS 121 -67.26 76.81 3 B ARG 149 -59.47 171.61 4 A LYS 72 -27.26 -61.66 4 A ASP 73 -144.55 44.59 4 A ARG 74 -178.57 144.27 4 A GLU 105 -66.43 -175.52 4 A GLU 106 -25.64 116.44 4 A GLN 108 -45.48 109.44 4 A ASP 109 -164.15 -136.73 4 A HIS 111 -111.43 79.80 4 A LYS 121 -68.59 78.93 4 A PRO 125 -46.24 153.32 4 B LYS 72 -27.25 -61.60 4 B ASP 73 -144.56 44.55 4 B ARG 74 -178.58 144.25 4 B GLU 105 -66.59 -175.57 4 B GLU 106 -25.56 116.42 4 B GLN 108 -45.30 109.42 4 B ASP 109 -164.15 -136.77 4 B HIS 111 -111.26 79.74 4 B LYS 121 -68.59 78.95 4 B PRO 125 -46.37 153.35 5 A LYS 72 -27.54 -58.99 5 A ASP 73 -152.82 56.68 5 A ARG 74 -160.22 106.81 5 A VAL 81 -144.02 31.35 5 A LYS 82 -89.37 45.28 5 A HIS 83 -141.32 -5.20 5 A VAL 100 -68.54 87.53 5 A ARG 149 -48.95 151.73 5 B LYS 72 -27.54 -58.89 5 B ASP 73 -152.87 56.73 5 B ARG 74 -160.30 106.80 5 B VAL 81 -144.09 31.40 5 B LYS 82 -89.23 45.02 5 B HIS 83 -141.20 -5.15 5 B VAL 100 -68.57 87.63 5 B ARG 149 -48.88 151.76 6 A GLU 71 -67.13 -175.61 6 A ASP 73 -149.93 36.38 6 A ASP 109 -116.95 -169.98 6 A ARG 149 -76.55 -169.20 6 B GLU 71 -67.11 -175.60 6 B ASP 73 -149.76 36.34 6 B ARG 149 -76.42 -169.21 7 A LYS 72 -28.19 -59.52 7 A LYS 82 -27.47 -59.19 7 A ASP 109 -133.59 -158.17 7 A HIS 119 -162.53 60.95 7 A LYS 150 -36.93 110.23 7 B LYS 72 -28.19 -59.64 7 B LYS 82 -27.54 -59.03 7 B ASP 109 -133.40 -158.20 7 B HIS 119 -162.42 61.01 7 B LYS 150 -36.88 110.27 8 A GLU 71 -68.38 -176.30 8 A LYS 72 -27.15 -60.17 8 A ASP 73 -142.54 26.78 8 A HIS 101 -103.05 64.75 8 A ASP 109 -160.36 -149.79 8 A HIS 119 -163.60 62.45 8 B GLU 71 -68.11 -176.25 8 B LYS 72 -27.29 -60.24 8 B ASP 73 -142.34 26.74 8 B HIS 101 -102.98 64.72 8 B ASP 109 -160.32 -149.70 8 B HIS 119 -163.64 62.34 9 A LYS 72 -29.11 -57.35 9 A PHE 75 -172.50 84.58 9 A ILE 98 -119.02 68.51 9 A GLU 99 -54.95 100.95 9 A ARG 120 -68.15 93.81 9 A LYS 121 -68.09 76.60 9 A TYR 122 -59.49 106.86 9 B LYS 72 -29.11 -57.36 9 B PHE 75 -172.51 84.58 9 B ILE 98 -119.03 68.47 9 B GLU 99 -54.92 100.88 9 B ARG 120 -68.14 93.92 9 B LYS 121 -68.04 76.53 9 B TYR 122 -59.58 106.86 closest to the average, model1 Chemical shift assignments and structure of the alpha-crystallin domain from human, HSPB5 1 N N 1 N N A ASP 129 A ASP 66 HELX_P A ILE 133 A ILE 70 5 1 5 B ASP 129 B ASP 66 HELX_P B ILE 133 B ILE 70 5 2 5 METAL BINDING PROTEIN crystallin, human, ACD, Protein, METAL BINDING PROTEIN A GLY 112 A GLY 49 5 A PHE 113 A PHE 50 9.52 B GLY 112 B GLY 49 5 B PHE 113 B PHE 50 9.62 CRYAB_HUMAN UNP 1 64 P02511 GLSEMRLEKDRFSVNLDVKHFSPEELKVKVLGDVIEVHGKHEERQDEHGFISREFHRKYRIPADVDPLTITSSLSSDGVL TVNGPRKQV 64 152 2N0K 64 152 P02511 A 1 1 89 64 152 2N0K 64 152 P02511 B 1 1 89 1 ASN engineered mutation ASP 146 2N0K A P02511 UNP 146 83 2 ASN engineered mutation ASP 146 2N0K B P02511 UNP 146 83 6 6 anti-parallel anti-parallel anti-parallel anti-parallel anti-parallel anti-parallel anti-parallel anti-parallel A PHE 75 A PHE 12 A LEU 79 A LEU 16 A VAL 142 A VAL 79 A ASP 146 A ASP 83 A THR 134 A THR 71 A LEU 137 A LEU 74 A LEU 89 A LEU 26 A LEU 94 A LEU 31 A VAL 97 A VAL 34 A HIS 104 A HIS 41 A GLY 112 A GLY 49 A ARG 123 A ARG 60 B GLY 112 B GLY 49 B ARG 123 B ARG 60 B VAL 97 B VAL 34 B HIS 104 B HIS 41 B LEU 89 B LEU 26 B LEU 94 B LEU 31 B PHE 75 B PHE 12 B LEU 79 B LEU 16 B VAL 142 B VAL 79 B ASP 146 B ASP 83 B THR 134 B THR 71 B LEU 137 B LEU 74